Influencing factors in quantitative measurement using activated platelet levels and platelet‐activating capacity for the assessment of thrombosis in pre‐metabolic syndrome and type 2 diabetes mellitus

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nursing and Health Sciences

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nhs.12389PMID 29235231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RhoA/ROCK signaling contributes to sex differences in the activation of human platelets.

  2016cited by this paper
• Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease

  2016cited by this paper
• Endothelial and platelet markers in diabetes mellitus type 2.

  2015cited by this paper
• Guidelines for the Management of Hypertension

  2015cited by this paper
• Role of multiligand/RAGE axis in platelet activation.

  2014cited by this paper
• Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.

  2013cited by this paper
• Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.

  2013cited by this paper
• Simultaneous assay of activated platelet count and platelet‐activating capacity by P‐selectin detection using K2‐EDTA‐treated whole blood for antiplatelet agents

  2012cited by this paper
• Platelet activation in obesity and metabolic syndrome

  2012cited by this paper
• Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: role of biomarkers.

  2011cited by this paper
• Development of an improved assay system for activated platelet counts and evaluation by aspirin monitoring.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

  2010cited by this paper
• Methods for the measurement of platelet function.

  2009cited by this paper
• Advanced glycation end products strongly activate platelets

  2009cited by this paper
• Gender differences in risk factors for coronary heart disease.

  2009cited by this paper
• From low-density lipoprotein to platelet activation.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.

  2008cited by this paper
• Platelet activation and atherothrombosis.

  2007cited by this paper
• Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.

  2006cited by this paper
• Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.

  2006cited by this paper
• High glucose levels enhance platelet activation: involvement of multiple mechanisms

  2006cited by this paper
• [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results].

  2005cited by this paper
• Small low-density lipoprotein particles and endothelium-dependent vasodilation in postmenopausal women.

  2004cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress.

  2003cited by this paper
• Low-density lipoprotein and its effect on human blood platelets

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Preanalytical Recommendations of the ‘Groupe d’Etude sur l’Hémostase et la Thrombose’ (GEHT) for Venous Blood Testing in Hemostasis Laboratories

  2001cited by this paper
• Comment on the provisional report from the WHO consultation

  1999cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper
• Assessment of platelet function assays.

  1998cited by this paper
• Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.

  1998cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper
• Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells.

  1989cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Platelets and diabetes mellitus.

  1977cited by this paper
• Menopause and risk of cardiovascular disease: the Framingham study.

  1977cited by this paper
• Menopause and Risk of Cardiovascular Disease: The Framingham Study

  1976cited by this paper

• The modern view on the role of glyprolines by metabolic syndrome

  2020cites this paper